ProfileGDS5822 / ILMN_1218362
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 9% 8% 22% 34% 25% 13% 10% 17% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 19.89
GSM1276600PDAC Late Ablation Control 211.18
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 111.822
GSM1276603PDAC Late Ablation 216.634
GSM1276604PDAC Late Ablation 313.625
GSM1303940PDAC Late Ablation_anti-CTLA4 110.513
GSM1303941PDAC Late Ablation_anti-CTLA4 26.910
GSM1303942PDAC Late Ablation_anti-CTLA4 39.517